Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Isopropamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 known ✓ | P20309 | 7/20 | 1.00 |
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 4/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 3/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.97 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.97 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.45 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.45 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.45 |
| ▸ | PGR | P06401 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.45 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.45 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopropamide SCHEMBL100255 | 0.98 | KDM4E (1.00) | CHRM3CHRM2KCNH2CYP2D6LMNA | |
| Isopropamide SCHEMBL3082703 | 0.98 | CHRM3 (0.97) | CHRM3CHRM2KCNH2CYP2D6LMNA | |
| Isopropamide SCHEMBL14672609 | 0.97 | CHRM3 (0.94) | CHRM3CHRM2KCNH2CYP2D6LMNA | |
| Isopropamide SCHEMBL7796559 | 0.92 | CHRM3 (0.85) | CHRM3CHRM2KCNH2CYP2D6LMNA | |
| SCHEMBL4538265 | 0.89 | CHRM3 (0.80) | CHRM3CHRM2KCNH2CYP2D6LMNA | |
| Isopropamide SCHEMBL17923572 | 0.88 | KDM4E (0.79) | CHRM3CHRM2KCNH2CYP2D6LMNA | |
| Ambutonium SCHEMBL11946672 | 0.80 | CHRM3 (0.67) | CHRM3CHRM2KCNH2CYP2D6LMNA | |
| Ambutonium SCHEMBL249674 | 0.79 | CHRM3 (0.65) | CHRM3CHRM2KCNH2CYP2D6LMNA | |
| SCHEMBL25341236 | 0.78 | CHRM3 (0.63) | CHRM3CHRM2KCNH2CYP2D6LMNA | |
| Hydrochloric Acid SCHEMBL30307081 | 0.76 | CHRM3 (0.61) | CHRM3CHRM2KCNH2CYP2D6LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3995 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| US-20250302814-A1 | METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA | APNIMED, INC. (DELAWARE) | 2025-10-02 | — | — | US | claimed |
| EP-4154879-B1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NICOTINE WITHDRAWAL SYMPTOMS | KOREA INST SCI & TECH (KR) | 2025-09-10 | — | — | EP | claimed |
| US-20250241933-A1 | METHODS OF TREATING SLEEP APNEA WITH A COMBINATION OF A CANNABINOID AND A CARBONIC ANHYDRASE INHIBITOR | APNIMED, INC. (DELAWARE) | 2025-07-31 | — | — | US | claimed |
| WO-2025137591-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR PROMOTING ZINC SOLUBILIZATION AND ZINC UPTAKE IN PLANTS | Tenfold Technologies, LLC (US) | 2025-06-26 | — | — | WO | claimed |
| CN-120076713-A | Stable oil dispersions | 安道麦阿甘有限公司 | 2025-05-30 | — | — | CN | claimed |
| EP-4543431-A1 | METHODS OF TREATING SLEEP APNEA WITH A COMBINATION OF A CANNABINOID AND A CARBONIC ANHYDRASE INHIBITOR | APNIMED, INC. (DELAWARE) (US) | 2025-04-30 | — | — | EP | claimed |
| CN-119677410-A | Herbicidal compositions comprising azine compounds | 巴斯夫欧洲公司 | 2025-03-21 | — | — | CN | claimed |
| US-20240358709-A1 | METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA | APNIMED, INC. (DELAWARE) | 2024-10-31 | — | — | US | claimed |
| CN-118785929-A | Three-dimensional biocompatible matrix and application thereof in wound treatment | 阿克森诺尔生命科学股份公司 | 2024-10-15 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| CN-1227597-A | Cleaning compositions | PROCTER & GAMBLE (US) | 1999-09-01 | — | — | CN | claimed |
| CN-1227592-A | Cleaning compositions | PROCTER & GAMBLE (US) | 1999-09-01 | — | — | CN | claimed |
| CN-1227591-A | Cleaning compositions | PROCTER & GAMBLE (US) | 1999-09-01 | — | — | CN | claimed |
| US-5779661-A | Method of treating dysfunctional bladder syndromes by electromotive drug administration | PHYSION, S.R.L. (IT) | 1998-07-14 | — | — | US | claimed |
| EP-0721348-A1 | MONOGLYCERIDE/LACTATE ESTER PERMEATION ENHANCER | ALZA CORPORATION (US) | 1996-07-17 | — | — | EP | claimed |
| WO-1995009006-A1 | MONOGLYCERIDE/LACTATE ESTER PERMEATION ENHANCER | ALZA CORPORATION (US) | 1995-04-06 | — | — | WO | claimed |
| US-5023088-A | Drug delivery dispenser | ALZA CORPORATION (US) | 1991-06-11 | — | — | US | claimed |
| US-4824676-A | ANTICHOLINERGIC AGENT TO SUPPRESS PERSPIRATION | SCHERING CORPORATION (US) | 1989-04-25 | — | — | US | claimed |